Literature DB >> 24011462

Controlled release of ascorbic acid from gelatin hydrogel attenuates abdominal aortic aneurysm formation in rat experimental abdominal aortic aneurysm model.

Akiko Tanaka1, Tomomi Hasegawa1, Keisuke Morimoto1, Wulan Bao1, Jie Yu1, Yutaka Okita1, Yasuhiko Tabata2, Kenji Okada3.   

Abstract

OBJECTIVE: Abdominal aortic aneurysms (AAAs) are associated with oxidative stress and inflammatory response. We investigated the hypothesis that the known antioxidant ascorbic acid, which can also promote elastin and collagen production by smooth muscle cells, would prevent AAA formation in a rat model.
METHODS: An intraluminal elastase and extraluminal calcium chloride-induced rat AAA model was used, and the animals were divided into three groups: control (group C, n = 18), the aorta wrapped with a saline-impregnated gelatin hydrogel sheet (group G, n = 18), and the aorta wrapped with a gelatin hydrogel sheet incorporating ascorbic acid (group A, n = 18). Wrapping of the sheet was completed at the end of treatment for AAA creation. The aortic dilatation ratio was measured, and aortic tissues were further examined for oxidative stress and oxidative DNA damage using biochemical and histologic techniques.
RESULTS: Aortic dilatation at both 4 and 8 weeks was inhibited in group A (dilatation ratio [%] at 4 weeks: 186.2 ± 21.8 in group C, 152.3 ± 10.2 in group G, 126.8 ± 11.6 in group A; P < .0001; dilatation ratio [%] at 8 weeks: 219.3 ± 37.5 in group C, 194.0 ± 11.6 in group G, 145.7 ± 8.3 in group A; P = .0002). Elastin and collagen content were significantly preserved in group A (elastin, P = .0015; collagen, P < .0001). The messenger RNA expressions of matrix metalloproteinase (MMP)-9, monocyte chemotactic protein-1, interleukin-1β, and tissue necrosis factor-α (P = .0024, P < .0001, P < .0001, and P < .0001, respectively) were downregulated in group A (P = .0024), whereas tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 were both upregulated in group A (TIMP-1, P = .0014; TIMP-2, P < .0001). Gelatin zymography showed activities of pro-MMP-2, MMP-2, and MMP-9 were significantly suppressed in group C (P < .0001 for each). Reactive oxygen species expression and 8-hydroxydeoxyguanosine and cluster of differentiation 68 staining were significantly suppressed in group A (reactive oxygen species expression, P < .0001; 8-hydroxydeoxyguanosine-positive cells, P < .0001; cluster of differentiation 68 positive cells, P < .0001).
CONCLUSIONS: Controlled release of ascorbic acid using gelatin hydrogel sheet-attenuated AAA formation through antioxidant and anti-inflammatory effect, regulation of MMP-2, TIMP-1, and TIMP-2, and preserving elastin and collagen in this animal model.
Copyright © 2014 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24011462     DOI: 10.1016/j.jvs.2013.07.013

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  4 in total

1.  Glucagon-like peptide-1 prevented abdominal aortic aneurysm development in rats.

Authors:  Jie Yu; Keisuke Morimoto; Wulan Bao; Zhenhai Yu; Yutaka Okita; Kenji Okada
Journal:  Surg Today       Date:  2015-12-13       Impact factor: 2.549

2.  Effects of vitamin C treatment on collar-induced intimal thickening.

Authors:  Mehmet Zuhuri Arun; Levent Üstünes; Gülnur Sevin; Erdener Özer
Journal:  Drug Des Devel Ther       Date:  2015-12-15       Impact factor: 4.162

3.  TIMP‑3 suppresses the proliferation and migration of SMCs from the aortic neck of atherosclerotic AAA in rabbits, via decreased MMP‑2 and MMP‑9 activity, and reduced TNF‑α expression.

Authors:  Huan Zhai; Xun Qi; Zixuan Li; Wei Zhang; Chenguang Li; Lu Ji; Ke Xu; Hongshan Zhong
Journal:  Mol Med Rep       Date:  2018-06-26       Impact factor: 2.952

4.  A Novel Hybrid Drug Delivery System for Treatment of Aortic Aneurysms.

Authors:  Koichi Yoshimura; Hiroki Aoki; Chie Teruyama; Masumi Iijima; Hiromori Tsutsumi; Shun'ichi Kuroda; Kimikazu Hamano
Journal:  Int J Mol Sci       Date:  2020-08-02       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.